Pills may replace inhalers in half of asthma cases

Metered-dose inhalers have long been the only game in town for asthma sufferers despite their inefficient record in getting drugs to where they're needed and the difficulty some patients have--especially children--in using them properly. That will soon change, according to an analysis of data led by David Price of the University of Aberdeen in the U.K. and head of the company Respiratory Research. In-PharmaTechnologist reports that even though an orally administered leukotriene-receptor antagonist (LTRA) proved equally as effective as inhaled therapies, "they concluded the pill was easier to administer and more patients preferred it." Price tells in-PharmaTechnologist that LTRA use will likely be used as first-line therapy, with inhalers used only when the pills fail to work. Price estimates that means about half of all asthma patients will begin to use oral medication. More here

Suggested Articles

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.